Alzheimer's Disease Trial, Recruiting NCT07324161 Sponsor: Fujian Medical University Union Hospital Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT07324161
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Alzheimer's disease according to specific medical guidelines from 2018
  • Your diagnosis also meets a standard set of criteria used to classify mental and brain disorders (DSM-5)
  • Your Alzheimer's is considered mild to moderate in severity (not early-stage or very advanced)
  • There is medical evidence of Alzheimer's-related changes in your brain, shown through a brain scan, a sample of fluid from your spine, or a blood test (confirm with trial site)

Who may not be able to join:

  • You have a medical reason why you cannot safely receive a type of brain stimulation treatment called rTMS (for example, having a metal implant in or near your head — confirm with trial site)
  • You have serious health complications or a disease affecting your immune system
  • You are unable to follow or participate in the study procedures for any reason
  • You have a history of epilepsy or seizures

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13395080173

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fujian Medical University Union Hospital
Registry
ClinicalTrials.gov
Start date
16 April 2025
Est. completion
30 April 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

MoCA Changes from baseline to post-treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov